Furthermore, Human recombinant soluble ACE2 (hrsACE2) has emerged as a potential therapeutic candidate for COVID-19 due to its ability to bind SARS-CoV-2 and potentially reduce viral entry into host cells [44]. The gene discussed is ACE2; the disease is COVID-19.